The global market for Automated and Rapid Microbiological Tests is estimated at US$6.3 Billion in 2023 and is projected to reach US$10 Billion by 2030, growing at a CAGR of 5.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Automated and Rapid Microbiological Tests Market]( "Automated and Rapid Microbiological Tests Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the GC/CRT (Clinical) segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of 7%. The AISS (Clinical) segment is also set to grow at 3.3% CAGR over the next 8 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $2.4 Billion in 2023, and China, forecasted to grow at an impressive 8.1% CAGR to reach $1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Automated and Rapid Microbiological Tests Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Automated and Rapid Microbiological Tests Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Automated and Rapid Microbiological Tests Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 3M Company, Abbott Laboratories, Inc., Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 77 Featured):
- 3M Company
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Abbott Molecular, Inc.
- American Type Culture Collection (ATCC)
- Biocartis NV
- Biomerica, Inc.
- AutoGenomics, Inc.
- BioControl Systems, Inc.
- BioFire Diagnostics LLC
- BIT Analytical Instruments GmbH
- Biosystems S.A.
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Automated and Rapid Microbiological Tests: An Introduction
- Enabling Technologies of Automated & Rapid Microbiological Tests
- Clinical Applications of Automated & Rapid Microbiological Tests
- Applications in Non-Clinical Investigations
- Global Market Prospects & Outlook
- Evolutionary Battle against Microbes Drives Market Future
- Clinical Applications Lead the Global Market for Automated and Rapid Microbiological Testing
- Developed Regions Lead, Developing Economies to Boost Future Growth
- Competition
- Recent Market Activity
- Automated and Rapid Microbiological Tests - Global Key Competitors Percentage Market Share in 2023 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
3. MARKET TRENDS & DRIVERS
- Rapid Diagnostics Bring in a Transformation to Clinical Testing Practices
- Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
- Lab Automation Trend Augurs Well for Microbiological Testing Labs
- Traditional Approaches Give Way to Modern Automated Microbiology Systems
- Microbiology Laboratories Switch to Automation to Push Yields
- Growing Incidence of Infectious Diseases to Fuel Demand for Rapid Microbiology Testing
- Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
- Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
- Rising Prevalence of Respiratory Infections Drive Market Growth
- Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
- Rise in Prevalence of COPD Augments Demand
- Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
- Influenza Boosts Rapid Test Prospects
- Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Opportunities for Automated Microbiology Tests
- Percentage Share Breakdown of Global Deaths Linked to Air Pollution
- Most Polluted Countries Worldwide: Average PM2.5 concentration (µg/m³)
- Sustained Threat of HIV and Sexually Transmitted Diseases Amplify Need for Rapid Microbiological Testing
- Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region
- Number of AIDS-Related Deaths (in Thousands) by Region
- Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
- Home HIV Testing Emerges as a Lucrative Option
- Advancements in Molecular Diagnostics Drive Market Growth
- Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis
- Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
- Advancements in Molecular Diagnostics: A Boon for Rapid Microbiological Testing Market
- Biotechnology: A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests
- Healthcare Needs of the World’s Aging Population: Potential Opportunity in Store
- Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
- Increase in Healthcare Spending in Emerging Markets to Propel Demand for Automated Microbiological Testing
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050
- Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
- Integration of Clinical Microbiology with Cloud Computing
- Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
- Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential…
- Technological Advancements to Drive the Automated Microbiology Testing Market
- Focus on Safe and High-Quality Foods Propels Rapid Microbiological Testing
- Number of Food Allergen Recalls in the US: Breakdown by FDA-Regulated Foods and FSIS-Regulated Foods for 2019
- Foodborne Illness Outbreak Investigations in the US (2019 & 2020)
- Impact of COVID-19 on Food Safety Testing Industry
- Stringent Norms Necessitate Food Safety Testing
- Food Microbiology Testing Market on a Growth Spree
- Global Food Safety Testing Market Breakdown (in %) by Segment
- Rapid and Automated Tests Emerge as an Attractive Solution
- Leading Food Processors Exhibit Inclination Towards Rapid Microbiological Testing
- Automation of Food Microbiology Labs
- Poultry Industry Embraces Rapid Microbiological Testing Technologies
- Rapid Microbial Testing in Dairy Industry
- Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing
- Technical and Cost Related Hurdles Hamper the Microbiology Testing Market
- Rapid Microbiological Testing Gains Significance in the Pharmaceutical Industry
- Key Advantages of Rapid Microbiological Tests for Pharmaceutical Industry
- Growing Importance of Rapid Microbiological Testing for Pharma Laboratories
- Key RMM Technologies for Pharmaceutical Industry
- Adoption of Rapid Methods for QC Microbiology in Biopharmaceuticals
- Advancements in Rapid Microbiological Testing for Pharmaceutical Industry
- Rapid Microbial Testing for Regenerative Medicine: An Emerging Space
- Rapid Microbiological Methods and the Regulatory Environment in Drug Development Industry
- FDA’s Requirements for Validation of RMM
- EMA’s Guidance on Use of RMMs for Water Testing
- Rapid Microbial Testing Emerges as an Important Means for Quality Control of Advanced Therapies
- Antibiotic Resistant Bacteria Throws the Spotlight on Rapid Microbial Testing Tools
- Antimicrobial Vulnerability Testing and Identification of Microbial strains
- Role of Microscopy in Antimicrobial Susceptibility Testing
- Rising Prominence of NAAT-Driven AST
- Economic Factors Promise Growth for Rapid AST
- Rapid Technologies Gain Momentum in Environment Testing Field
- Deteriorating Quality of Water Throws Emphasis on Water Testing Services
- Percentage of Contaminated Water in Drinking Water Supplies in Africa, Asia, and Latin America and Caribbean
- Key Issues Confronting the Rapid Microbiological Tests Market
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for GC/CRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for GC/CRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for AISS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for AISS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for ABCS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for ABCS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for SIRT (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for SIRT (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for ATS (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for ATS (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 20: World Historic Review for Other Applications (Clinical) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 21: World 16-Year Perspective for Other Applications (Clinical) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 23: World Historic Review for Non-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 24: World 16-Year Perspective for Non-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 25: World Automated and Rapid Microbiological Tests Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Rising Threat of Infectious Diseases Drive Significance of Rapid Microbiological Testing
- Unmet Diagnostic Needs of Aging Population: Major Driver
- US Elderly Population: Expected Growth Rates Over the Years 2005-2025
- North American Aging Population by Age Group: 1975-2050
- Select Product Categories in Rapid Microbiological Testing - An Overview
- Automated Susceptibility Testing Systems
- STD Rapid Tests
- Respiratory Rapid Tests
- Streptococcus Infection Rapid Tests
- Food Safety Microbiological Testing Market: Concerns over Food Safety Drive Market Gains
- Foodborne Illnesses, Hospitalizations and Deaths in the US: Percentage Breakdown for Known Pathogens and Unspecified Agents
- Leading Pathogens Causing Foodborne Illnesses in the US: Percentage Breakdown of Number of Illnesses by Known Pathogens
- Table 26: USA Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 27: USA Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 28: USA 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
CANADA
- Table 29: Canada Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 30: Canada Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 31: Canada 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
JAPAN
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Market Overview
- Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
- Table 32: Japan Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: Japan Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 34: Japan 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
CHINA
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Market Overview
- Table 35: China Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 36: China Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 37: China 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
EUROPE
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Growth in Clinical Diagnostics Automation
- Rise in Automated and Rapid Tests in Clinical Applications
- Aging Demography: An Opportunity Indicator
- Food Safety Testing Market in Europe: An Overview
- Table 38: Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 39: Europe Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 40: Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 41: Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 42: Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 43: Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
FRANCE
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 44: France Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 45: France Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 46: France 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
GERMANY
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 47: Germany Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 48: Germany Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 49: Germany 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
ITALY
- Table 50: Italy Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 51: Italy Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 52: Italy 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 53: UK Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 54: UK Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 55: UK 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
SPAIN
- Table 56: Spain Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: Spain Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 58: Spain 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
RUSSIA
- Table 59: Russia Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 60: Russia Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 61: Russia 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 62: Rest of Europe Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: Rest of Europe Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 64: Rest of Europe 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Market Overview
- Table 65: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 66: Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 67: Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 69: Asia-Pacific Historic Review for Automated and Rapid Microbiological Tests by Application - GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 70: Asia-Pacific 16-Year Perspective for Automated and Rapid Microbiological Tests by Application - Percentage Breakdown of Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical), Other Applications (Clinical) and Non-Clinical for the Years 2014, 2024 & 2030
AUSTRALIA
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- Market Overview
- Demand for Automated and Rapid Microbiology Testing Poised for Growth
- Automation - Name of the Game
- Private Enterprises Encourage Changes in Diagnostics Sector
LATIN AMERICA
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
MIDDLE EAST
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICA
- Automated and Rapid Microbiological Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Company
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Abbott Molecular, Inc.
- American Type Culture Collection (ATCC)
- Biocartis NV
- Biomerica, Inc.
- AutoGenomics, Inc.
- BioControl Systems, Inc.
- BioFire Diagnostics LLC
- BIT Analytical Instruments GmbH
- Biosystems S.A.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 489 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 6.3 Billion |
| Forecasted Market Value ( USD | $ 10 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
